Why in news? Researchers found that keratoconus severity before treatment is a key factor in disease progression, even after collagen cross-linking (CXL) treatment.
About Keratoconus
Keratoconus is a progressive eye condition in which the normally dome-shaped cornea thins and gradually bulges outward into a cone shape.
This cone-shaped cornea causes irregular astigmatism and myopia, leading to distorted and blurry vision.
The condition typically begins in the teenage years and progresses during the teens and twenties, but it can vary among individuals.
The exact cause of keratoconus is unknown, but it is considered multifactorial, involving both genetic and environmental factors.
Genetic predisposition is evident as family history increases risk, and certain connective tissue disorders (such as Ehlers-Danlos syndrome and osteogenesis imperfecta).
Environmental factors include persistent eye rubbing, atopy (allergic conditions), asthma, and exposure to ultraviolet light.
Symptoms
Blurred or distorted vision
Increased nearsightedness and irregular astigmatism
Light sensitivity and glare
Difficulty with night vision
Vision correction problems with glasses over time
Diagnosis and Treatment
Diagnosis is primarily by clinical examination and advanced corneal imaging techniques such as corneal topography, which maps the cornea’s shape.
Treatments are tailored to disease severity:
Early: Glasses or soft contact lenses
Moderate: Rigid gas-permeable or scleral lenses
To halt progression: Corneal collagen cross-linking
Advanced with scarring or intolerance to lenses: Corneal transplant surgery